Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-023028
Filing Date
2024-09-06
Accepted
2024-09-06 17:32:12
Documents
1
Period of Report
2024-04-22

Document Format Files

Seq Description Document Type Size
1 form4a-09062024_090909.html 4/A  
1 form4a-09062024_090909.xml 4/A 3857
  Complete submission text file 0001415889-24-023028.txt   5443
Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 699 BOYLSTON STREET, 8TH FLOOR BOSTON MA 02116
Business Address
Munshi Amit (Reporting) CIK: 0001612551 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40598 | Film No.: 241285351

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)